新澳门资料大全正版资料4不像,2025澳门管家婆正版资料 ,2025正版免费资料大全,22324濠江论坛一肖一码

參考文獻(xiàn)：
[1] 李玉宇.偏頭痛診斷與防治專家共識[J].中國農(nóng)村衛(wèi)生,2015,(02):95-96.
[2] 林燕,張文武,陳濤,陳鄧,劉凌.偏頭痛患者腦血管病一級預(yù)防證據(jù)評價[J].中國現(xiàn)代神經(jīng)疾病雜
志,2015,15(01):33-38.
[3] 陳明波,劉志明,朱紅雯.偏頭痛發(fā)病機(jī)理及臨床治療進(jìn)展[J].中外醫(yī)療,2011,30(21):192.
[4] 余傳勇,黃琳.偏頭痛發(fā)病與 Willis 環(huán)不完整性的相關(guān)性研究[J].臨床神經(jīng)病學(xué)雜志,2019,32(06):423-425.
[5] 李巖密,李越,鄧玉嬌,伊海瑞. 右心聲學(xué)造影診斷偏頭痛患者中卵圓孔未閉的研究[C]//.中國超聲醫(yī)學(xué)工
程學(xué)會第十三屆全國超聲心動圖學(xué)術(shù)會議論文匯編.[出版者不詳],2016:37-38.
[6] 陳怡,余成.偏頭痛臨床分期靜息態(tài)腦功能連接研究進(jìn)展[J].臨床放射學(xué)雜志,2020, 39(04): 822-824. DOI: 
10.13437/j.cnki.jcr. 2020.04.044.
[7] 杜業(yè)亮.偏頭痛的臨床表現(xiàn)和注意事項[J].中國醫(yī)刊,2006(12):14-17.
[8] Queiroz LP, Friedman DI, Rapoport AM, et al. Cephalalgia, 2011, 31:1652．
[9] 劉唯,嚴(yán)滿云,郭效寧,許春陽,陸佳潔,王靜雯,張全全,陸海鋒,趙紅如.叢集性頭痛的發(fā)作分期及臨床特征研
究[J].中國臨床神經(jīng)科學(xué),2020,28(06):641-648.
[10] 王國建,王喜臣,胡英華.針刺蝶腭神經(jīng)節(jié)治療慢性緊張性頭痛的臨床觀察[J].河北中醫(yī), 2020, 
42(01):111-114.
[11]偏頭痛的鑒別診斷[N]. 農(nóng)村醫(yī)藥報(漢),2006-06-13(005).DOI: 10.28594/n.cnki.nncyh.2006.001025.
[12]宋吉貴,陳大燕. 偏頭痛的診斷和鑒別診斷[C]. //中華醫(yī)學(xué)會第七次全國物理醫(yī)學(xué)與康復(fù)學(xué)學(xué)術(shù)會議. 
2005:102-104.
[13]周柏玉,劉小輝,張艷俠. 痛性眼肌麻痹的研究進(jìn)展[J]. 國際眼科雜志,2012,12(9):1683-1685. DOI: 
10.3969/j.issn.1672-5123.2012.09.21.
[14] Clemow DB, Johnson KW, Hochstetler HM, Ossipov MH, Hake AM, Blumenfeld AM. Lasmiditan
mechanism of action: review of a selective 5-HT(1F) agonist[J]. J Headache Pain, 2020, 21: 71.
[15] Ashina M. Migraine[J]. N Engl J Med, 2020, 383:1866-1876.
[16] Diener HC. The risks or lack thereof of migraine treatments in vascular disease[J]. Headache, 2020, 
60:649-653.
[17] Steiner TJ, Jensen R, Katsarava Z, Linde M, MacGregor EA, Osipova V, Paemeleire K, Olesen J, Peters M, 
Martelletti P.Aids to management of headache disorders in primary care (2nd edition): on behalf of the European 
Headache Federation and Lifting The Burden: the Global Campaign against Headche[J]. J Headache Pain, 2019, 
20:57.
[18] Parikh S. Lasmiditan for acute treatment of migraine[J]. Drugs Today (Barc), 2021, 57:89-100.
[19] Negro A, Martelletti P. Novel synthetic treatment options for migraine[J]. Expert Opin Pharmacother, 2021, 
22:907-922.
[20] Van Hoogstraten WS, Maassen Van DenBrink A. The need for new acutely acting antimigra